Literature DB >> 6316121

The role of immunoglobulins in amniotic fluid growth inhibition of Bacteroides fragilis, herpes simplex, coxsackie B 5 and cytomegalovirus.

G Evaldson, I Blomberg, L Grillner, C E Nord, A Weintraub.   

Abstract

In serum and amniotic fluid (AF) from 30 pregnant women, antibodies against the anaerobe Bacteroides fragilis were determined by enzyme-linked immunosorbent assay (ELISA) and the results were compared with those of previously performed tests of B. fragilis growth inhibition by AF. The neutralizing effects of serum and AF against herpes simplex virus (HSV), cytomegalovirus (CMV) and coxsackie B 5 virus were also investigated, and antibody titres were determined by ELISA. No correlation could be demonstrated between the growth-inhibitory capacity of AF and the presence of antibodies against B. fragilis in serum or AF. Neutralizing antibodies against HSV and coxsackie B 5 virus were found in 73% and 51%, respectively, of the sera and in 36% and 13%, respectively, of both serum and corresponding AF. In no case could an AF neutralizing effect upon HSV, coxsackie B5 or CMV be demonstrated without a corresponding positive serum neutralization. It is concluded that the growth-inhibitory effect of AF on viruses in antibody-mediated, while AF inhibition of B. fragilis, and possibly other bacteria as well, seems to depend upon other antimicrobial mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316121     DOI: 10.1007/bf02123800

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  Bacterial growth inhibition by amniotic fluid. III. Demonstration of the variability of bacterial growth inhibition by amniotic fluid with a new plate-count technique.

Authors:  P Schlievert; B Larsen; W Johnson; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1975-08-01       Impact factor: 8.661

2.  VIROLOGIC STUDIES ON CYTOMEGALIC INCLUSION DISEASE.

Authors:  G CARLSTROEM
Journal:  Acta Paediatr Scand       Date:  1965-01

3.  The effect of amniotic fluid on bacterial growth in three population groups.

Authors:  P C Appelbaum; Y Holloway; S M Ross; I Dhupelia
Journal:  Am J Obstet Gynecol       Date:  1977-08-15       Impact factor: 8.661

4.  Antimicrobial effect of amniotic fluid.

Authors:  H Thadepalli; V T Bach; E C Davidson
Journal:  Obstet Gynecol       Date:  1978-08       Impact factor: 7.661

5.  Studies on the antimicrobial activity of amniotic fluid.

Authors:  J Miller; J Michel; B Bercovici; M Argaman; T Sacks
Journal:  Am J Obstet Gynecol       Date:  1976-05-15       Impact factor: 8.661

6.  Impairment of immunity during pregnancy and antiviral effect of amniotic fluid.

Authors:  A S Pacsa
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

7.  Evaluation of solubilized herpes simplex virus membrane antigens in diffusion in gel-enzyme-linked immunosorbent assay (DIG-ELISA).

Authors:  S Jeansson; H Elwing; H Nygren; S Olofsson
Journal:  J Virol Methods       Date:  1982-04       Impact factor: 2.014

8.  Microbiological findings in pregnant women with premature rupture of the membranes.

Authors:  G Evaldson; G Carlström; A Lagrelius; A S Malmborg; C E Nord
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  Antimicrobial effect of amniotic fluid against anaerobic bacteria.

Authors:  H Thadepalli; M D Appleman; J E Maidman; J J Arce; E C Davidson
Journal:  Am J Obstet Gynecol       Date:  1977-02-01       Impact factor: 8.661

10.  Neutralization of herpes simplex virus by antibody in amniotic fluid.

Authors:  J S Bradley; A S Yeager; D C Dyson; P A Hensleigh; A L Medearis
Journal:  Obstet Gynecol       Date:  1982-09       Impact factor: 7.661

View more
  3 in total

1.  Sexually transmitted viral infections in various population groups in Mogadishu, Somalia.

Authors:  H Jama; L Grillner; G Biberfeld; S Osman; A Isse; M Abdirahman; S Bygdeman
Journal:  Genitourin Med       Date:  1987-10

2.  Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia.

Authors:  A Ortqvist; S Hammers-Berggren; M Kalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

3.  Coxsackievirus B4 vertical transmission in a murine model.

Authors:  Hela Jaïdane; Aymen Halouani; Habib Jmii; Firas Elmastour; Moncef Mokni; Mahjoub Aouni
Journal:  Virol J       Date:  2017-01-31       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.